Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > RedChip Visibility Issues Research Update On BioForce Nanosciences Holdings, Inc.

Abstract:
RedChip Visibility, a division of RedChip Companies, Inc., announced that it has issued a second quarter research update on BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH).

RedChip Visibility Issues Research Update On BioForce Nanosciences Holdings, Inc.

Orlando, FL | Posted on October 26th, 2007

Tony Telan, RedChip Research Analyst, wrote in the report:

"BioForce Nanosciences, Inc.(OTCBB:BFNH), a developer of nanotechnology instruments, consumables, and applications for the life sciences industry, announced the completion of a financing transaction valued up to $3.45 million. The transaction entailed sales to an institutional investor of Series A 8% Convertible Preferred Stock at $0.50 per share and a series of warrants with exercise prices ranging from $0.50 to $1.25 per share. Notably, the transaction is structured at a fixed price and therefore protects the interests of current shareholders.

"In summary, we continue to believe BFNH offers a compelling investment opportunity for those seeking exposure to micro-cap nanotechnology equities. With a current market cap of less than $16 million, BFHN is undervalued given the expected trajectory of near-term revenue growth and the large ultimate market potential of the Company's product offering. Using sales of AFMs as a proxy for market size and assuming approximately 8,000 AFM sales to date yields a potential market of $1.3 billion (8,000 systems x $160,000 per system) for the NeN system, or $800 million assuming a lower sales target (5,000 systems). Note this analysis conservatively does not include 1) follow on sales of consumables (e.g. the "ink cartridge" and "paper"), 2) potential price increases for high throughput product enhancements or 3) intellectual property related to its ViriChip and Chip-on-a-Tip product development initiatives."

To receive a complimentary copy of the RedChip Visibility research update for BFNH, please visit:

http://www.redchip.com/visibility/about.asp?page=requestbfnh_q2_2007&from=newsbfnh10262007

####

About RedChip Companies, Inc.
RedChip Companies is an international small-cap research and financial public relations firm with offices in Beijing and Orlando and affiliates in New York and San Diego. RedChip delivers measurable results for its clients through its extensive international market expertise as well as its comprehensive platform of products: RedChip Research, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences held throughout the United States, RedChip Radio, and RedChip TV.

To learn more about RedChip's products and services please visit:

http://www.redchip.com/visibility/services.asp

Disclosures

The analysts contributing to this report do not hold any shares of BFNH. Additionally, the analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Additional information on the securities mentioned in this report is available upon request. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. As such, the report should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed herein are subject to change. BFNH is a client of RedChip Visibility, a division of RedChip Companies. BFNH paid RedChip Visibility $32,400 for the RedChip Visibility Research Program, which includes this report. RedChip Visibility has been contracted by BFNH to increase investor awareness of BFNH to the small-cap equity community. These services may include investor conferences and digital and print distribution of BFNH investor related materials. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that RedChip was hired by the Company and receives a monthly fee of $5,500 and warrants to purchase 80,000 shares of the Company's common stock.

For more information, please click here

Contacts:
BioForce Nanosciences
515-233-8333


RedChip Companies, Inc.
Investor Relations:
1-800-RedChip ext. 127

Copyright © PrimeNewswire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

Forge Nano 2017: 1st Quarter Media Update April 20th, 2017

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Caught on camera -- chemical reactions 'filmed' at the single-molecule level March 22nd, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Investments/IPO's/Splits

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Announcements

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

Ultracold atom waves may shed light on rogue ocean killers: Rice quantum experiments probe underlying physics of rogue ocean waves April 27th, 2017

Looking for the quantum frontier: Beyond classical computing without fault-tolerance? April 27th, 2017

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Video captures bubble-blowing battery in action: Researchers propose how bubbles form, could lead to smaller lithium-air batteries April 26th, 2017

Tools

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Affordable STM32 Cloud-Connectable Kit from STMicroelectronics Puts More Features On-Board for Fast and Flexible IoT-Device Development April 26th, 2017

Geoffrey Beach: Drawn to explore magnetism: Materials researcher is working on the magnetic memory of the future April 25th, 2017

NanoMONITOR shares its latest developments concerning the NanoMONITOR Software and the Monitoring stations April 21st, 2017

Nanobiotechnology

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Nano-SPEARs gently measure electrical signals in small animals: Rice University's tiny needles simplify data gathering to probe diseases, test drugs April 17th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project